Latest news with #FundVIII
Business Wire
a day ago
- Business
- Business Wire
Omega Funds Closes Oversubscribed $647 Million Fund VIII to Invest in Transformative Life Science Companies
BOSTON--(BUSINESS WIRE)-- Omega Funds, a leading international healthcare venture capital firm focused on delivering impactful medicines to patients, today announced the closing of its eighth fund with $647 million in capital commitments. The new fund, Omega Fund VIII, L.P. ("Fund VIII"), was oversubscribed, exceeding its target of $600 million, garnering strong support from both new and existing limited partners. With Fund VIII, the firm will continue to execute its strategy of creating and investing in innovative life sciences companies in the U.S. and Europe that target severe, unmet medical needs. Since its inception in 2004, Omega Funds has raised $2.5 billion to invest in exceptional entrepreneurs developing innovative products across multiple therapeutic areas, including oncology, immunology, rare diseases, medical devices, and precision medicine. Fund VIII builds upon the prior success of Omega Funds, resulting in 52 commercialized products being brought to market by Omega portfolio companies. The firm's investments have resulted in 50 exits via M&A, and 47 public listings. Omega's recent M&A exits and IPOs include SoniVie (acquired by Boston Scientific), Scorpion Therapeutics (acquired by Eli Lilly), Kestra Medical Technologies (NASDAQ: KMTS), Beta Bionics (NASDAQ: BBNX), Upstream Bio (NASDAQ: UPB), Bicara Therapeutics (NASDAQ: BCAX), Morphic Therapeutic (NASDAQ: MORF, acquired by Eli Lilly), EyeBio (acquired by Merck), Imago BioSciences (NASDAQ: IMGO, acquired by Merck), Amunix Pharmaceuticals (acquired by Sanofi), and Chord Therapeutics (acquired by Merck KGaA). 'We are very grateful to our investors for the support and trust, particularly given this exceptionally challenging fundraising environment. By exceeding its target size, Fund VIII is a recognition of our investment strategy and track record of consistent exits across market cycles,' said Otello Stampacchia, Founder and Managing Director of Omega Funds. 'We appreciate the partnership from both our longstanding and new limited partners.' 'As with prior funds, Fund VIII will support management teams in the U.S. and Europe through company creation, early venture rounds, and later-stage financings,' said Francesco Draetta, Managing Director of Omega Funds. 'We believe our broad investment strategy is well-positioned for navigating this period of macro and policy uncertainty. We look forward to contributing our capital, expertise, and network connectivity in partnering with entrepreneurs, founders, co-investors, and the broader community to transform the standards of care for severe diseases.' About Omega Funds Founded in 2004, Omega Funds is a leading international venture capital firm that creates and invests in life sciences companies that target our world's most urgent medical needs. Omega focuses on identifying and supporting companies through value inflection points across the full arc of innovation, from company formation through clinical milestones and commercial adoption. Omega Funds' portfolio companies have brought 52 commercialized products to market in multiple therapeutic areas, including oncology, rare diseases, precision medicine, medical devices, and others. Please visit for additional information.
Yahoo
02-05-2025
- Business
- Yahoo
Uncork Capital Raises $300 Million to Back the Next Generation of Category-Defining Companies
Firm Raises $225M Fund VIII and $75M Plus IV Growth Fund to reinforce its long-term commitment to leading at seed and backing breakout companies through scale SAN FRANCISCO, May 1, 2025 /PRNewswire/ -- Uncork Capital, one of Silicon Valley's most established early-stage venture capital firms today announced the close of $300 million in new capital across two funds: Uncork VIII, a $225 million seed fund, and Uncork Plus IV, a $75 million growth fund. "Through more than two decades—and multiple boom-and-bust cycles—we've consistently backed new ideas that became category-defining companies while backing bold founders at the earliest stages, when others hesitate," said Andy McLoughlin, Managing Partner at Uncork Capital. "In times of volatility, founders need conviction-backed capital more than ever. We believe this is one of the most compelling moments to build—and to invest in—the foundational technologies of tomorrow. These new funds position us to do just that." Uncork VIII will invest in early-stage startups across B2B software, developer tools, and infrastructure, continuing the firm's strategy of leading 35 seed rounds while maintaining significant follow-on reserves. The firm expects to write slightly larger checks with Fund VIII and target marginally higher initial ownership, reflecting a conviction-led approach. Through the Plus IV fund, Uncork will double down on its breakout portfolio companies as they reach their inflection point and scale. Uncork's portfolio spans multiple inflection-stage companies, including: Late-Stage: Human Interest, LaunchDarkly, Carrot Scaling Fast: Tailscale, Hallow, Loft Orbital, ClassDojo, Wrapbook, Crossbeam, and Fountain AI-Native and Early-Stage: GPTZero, Nuon, Ivo, Numeral, Final Round "Uncork has proven to be the most supportive and helpful investor on our cap table," said Jeff Schneble, CEO of Human Interest. "Their ability to effectively communicate our vision and progress to potential investors has been instrumental in raising hundreds of millions of dollars in capital. In fact, many of our current investors were initially introduced to us through Uncork, significantly accelerating our company's growth. They have consistently provided support at every stage and have actively participated in all our financing rounds. We consider Uncork to be one of the top early-stage investors in today's market and highly recommend them to anyone building a high-growth company." Uncork has built its reputation by backing transformative technologies years ahead of the curve—from early bets in AI to foundational SaaS infrastructure. With over 60 years of collective investing experience, the team reviews over 3,000 startups annually and invests in only the most exceptional founders. "We seek founders solving real problems with authentic insights, invest early in exceptional teams building transformative companies, and stay the course, said Amy Saper, Partner at Uncork. "Having backed AI-native startups for nearly a decade, we see some of our most exciting portfolio companies building on generative models and creating the infrastructure for the AI economy itself." Limited partners in the new funds include top-tier university endowments, pension funds, mission-aligned institutions, and repeat backers of the firm's prior vehicles—demonstrating sustained confidence in Uncork's disciplined strategy and founder-first ethos. "With a proven track record of identifying future tech leaders, a well-respected brand in the VC community, and a great team at its core, Uncork Capital has the vision, discipline, and founder alignment we look for," said Becky Connolly, Co-founder and Managing Partner at Tiger Iron Capital. "Their early recognition of breakthrough technologies and ongoing support for those companies make them ideal partners. We're proud to be part of their next chapter." The close of these funds marks Uncork's 21st year and ushers in a new chapter in the firm's evolution. Andy McLoughlin now steps into the role of sole managing partner, while founder Jeff Clavier steps back from day-to-day management and continues to invest in frontier tech and emerging innovation. About Uncork Capital Uncork Capital is a San Francisco-based venture capital firm that helps founders build category-defining companies from the earliest stages. For more than two decades, through multiple boom-and-bust cycles and across the tech landscape, the firm has backed over 275 companies, including Fitbit, Sendgrid, Eventbrite, Poshmark, and Postmates, as well as fast-growing startups like Human Interest, LaunchDarkly, Carrot Fertility, Tailscale, Loft Orbital, Hallow, Wrapbook, Crossbeam, Fountain, GPTZero, Nuon, Ivo, Numeral, and Final Round. Today, Uncork continues to support the next generation of builders shaping industries across AI, SaaS, infrastructure, consumer, and frontier tech. Learn more at or follow along on LinkedIn and X. Media ContactMichael Celiceo, CodePRmichaelc@ View original content to download multimedia: SOURCE Uncork Capital
Time of India
23-04-2025
- Business
- Time of India
A91 secures $665mn in 3rd fund for startup bets
BENGALURU: A91 Partners has finalised its third fund at $665 million, joining other India-focused venture firms that recently secured funding capital amid growing international attention. Founded in 2018 by four former executives of Sequoia Capital India (now Peak XV Partners), A91 focuses its investments across various sectors, including consumer, healthcare, financial services, and industrials. The organisation provides growth-stage funding between $10 million and $50 million. Their portfolio includes investments in companies such as Digit Insurance , Atomberg, and Push Health. The firm announced the fund closure on LinkedIn, emphasising their dedication to supporting Indian entrepreneurs for extended periods. "We started A91... with the belief that patient capital will play an important role in accelerating value creation in Indian businesses," the post read. This announcement follows other significant fundraising activities in India's venture space. Accel secured $650 million for its India and Southeast Asia-focused Fund VIII in Jan 2025, whilst Stellaris Venture Partners concluded its third fund at $300 million last year, maintaining its focus on early-stage investments in SaaS, consumer internet, and fintech. Despite reduced venture funding for Indian startups throughout 2023 and early 2024, institutional VC funds continue to attract substantial investment. Global limited partners maintain their confidence in India's long-term potential, particularly in areas driven by domestic consumption, digitalisation, and infrastructure development. Stay informed with the latest business news, updates on bank holidays and public holidays . Master Value & Valuation with ET! Learn to invest smartly & decode financials. Limited seats at 33% off – Enroll now!
Time of India
22-04-2025
- Business
- Time of India
A91 Partners closes third fund at $665 million
Photo credit- LinkedIn/ A91 Partners ) BENGALURU: A91 Partners has closed its third fund at $665 million, joining a recent wave of a handful India-focused venture firms raising larger pools of capital amid rising global interest in the country's private markets. Launched in 2018 by four former Sequoia Capital India (now called Peak XV Partners executives), A91 invests across sectors such as consumer, healthcare, financial services and industrials. The firm typically backs growth-stage startups with cheque sizes ranging from $10 million to $50 million. It has previously invested in companies including Digit Insurance, Atomberg Technologies and Push Health. In a LinkedIn post announcing the fund close, A91 said it remained committed to backing Indian entrepreneurs over long investment horizons. 'We started A91… with the belief that patient capital will play an important role in accelerating value creation in Indian businesses,' the post read. The close of Fund III follows other sizable raises in India's venture ecosystem. Accel announced a $650 million India and Southeast Asia-focused Fund VIII in January 2025, its largest to date. In November 2024, Stellaris Venture Partners closed a $300 million third fund, continuing its strategy of backing early-stage companies in SaaS, consumer internet and fintech. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Free P2,000 GCash eGift UnionBank Credit Card Undo While overall venture funding into Indian startups declined through much of 2023 and early 2024, investor appetite for institutional VC funds has remained strong. Several global limited partners continue to see India as a long-term bet, especially in segments where domestic consumption, digitisation and infrastructure shifts are driving business formation. With Fund III, A91 is among the larger India-dedicated capital pools currently active in the market, as firms sharpen focus on fewer, higher-conviction bets with clearer paths to profitability. Stay informed with the latest business news, updates on bank holidays and public holidays . Master Value & Valuation with ET! Learn to invest smartly & decode financials. Limited seats at 33% off – Enroll now!
